Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

TherapeuticsMD, Inc. TXMD

Set alert

Price alert · TXMD

All alert types
1.80 USD -0.03 -1.64%

At close · Oct 30

1.80 0.00 0.00%

After hours · Oct 30, 4:00 PM ET

Bid
1.80 × 1
Ask
1.83 × 1
1.80 Day range 1.82
1.15 52-week range 2.77
YTD
+10.43%
1 year
+45.16%
Open
1.80
Prev close
1.83
Mkt cap
20.83M
Vol
3.83K
Avg vol
23.74K
EPS
-0.04
P/E
0.00
Div yield
0.00%
More statistics
Low
1.80
High
1.82
Forward P/E
3.13
Beta
0.00
Short ratio
0.95
Inst. own
44.53%
Dividend
0.00
Ex-div date
50-d avg
1.42
200-d avg
1.79
1y target
0.00

5D chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The five-day price history for TXMD has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

-34.37 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

4 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C+2 / 5 overall

  • DCF 2
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 3
  • P/E 1
  • P/B 4

Valuation

P/E -33.1×
FY 2016: -12.6×FY 2017: -16.1×FY 2018: -6.5×FY 2019: -3.0×FY 2020: -1.6×FY 2021: -0.7×FY 2022: 0.5×FY 2023: -4.1×FY 2024: -4.5×FY 2025: -33.1×
FY 2016 5y median -4.1× FY 2025
P/S 6.2×
FY 2016: 58.5×FY 2017: 74.0×FY 2018: 53.3×FY 2019: 12.0×FY 2020: 5.1×FY 2021: 55.7×FY 2022: 0.7×FY 2023: 18.0×FY 2024: 5.6×FY 2025: 6.2×
FY 2016 5y median 6.2× FY 2025
P/B 0.7×
FY 2016: 8.9×FY 2017: 9.6×FY 2018: 8.8×FY 2019: 64.8×FY 2020: -2.7×FY 2021: -1.5×FY 2022: 1.4×FY 2023: 0.8×FY 2024: 0.4×FY 2025: 0.7×
FY 2016 5y median 0.7× FY 2025
P/FCF 7.8×
FY 2016: -16.1×FY 2017: -16.1×FY 2018: -6.7×FY 2019: -3.1×FY 2020: -2.1×FY 2021: -1.0×FY 2022: -11.4×FY 2023: 0.0×FY 2024: 13.5×FY 2025: 7.8×
FY 2016 5y median 0.0× FY 2025
EV/EBITDA -5.8×
FY 2016: -11.1×FY 2017: -14.5×FY 2018: -6.0×FY 2019: -4.0×FY 2020: -3.3×FY 2021: -3.5×FY 2022: 1.8×FY 2023: -3.6×FY 2024: -2.8×FY 2025: -5.8×
FY 2016 5y median -3.5× FY 2025
EV/Sales 5.8×
FY 2016: 51.7×FY 2017: 66.4×FY 2018: 47.8×FY 2019: 12.9×FY 2020: 7.7×FY 2021: 107×FY 2022: 0.3×FY 2023: 20.9×FY 2024: 6.8×FY 2025: 5.8×
FY 2016 5y median 6.8× FY 2025
FCF Yield 12.9%
FY 2016: -6.2%FY 2017: -6.2%FY 2018: -14.9%FY 2019: -31.8%FY 2020: -48.3%FY 2021: -103.2%FY 2022: -8.8%FY 2023: 0.0%FY 2024: 7.4%FY 2025: 12.9%
FY 2016 5y median 0.0% FY 2025

Profitability

Gross Margin 100.0%
FY 2016: 78.4%FY 2017: 84.3%FY 2018: 83.0%FY 2019: 87.2%FY 2020: 75.4%FY 2021: 45.5%FY 2022: 98.0%FY 2023: 100.0%FY 2024: 100.0%FY 2025: 100.0%
FY 2016 5y median 100.0% FY 2025
Operating Margin -139.4%
FY 2016: -466.3%FY 2017: -462.7%FY 2018: -808.8%FY 2019: -304.6%FY 2020: -239.8%FY 2021: -3092.8%FY 2022: 15.2%FY 2023: -654.6%FY 2024: -275.1%FY 2025: -139.4%
FY 2016 5y median -275.1% FY 2025
Net Margin -18.8%
FY 2016: -464.3%FY 2017: -458.5%FY 2018: -823.7%FY 2019: -354.8%FY 2020: -282.9%FY 2021: -6700.9%FY 2022: 160.1%FY 2023: -789.4%FY 2024: -123.9%FY 2025: -18.8%
FY 2016 5y median -123.9% FY 2025
ROE -2.1%
FY 2016: -70.5%FY 2017: -59.2%FY 2018: -136.0%FY 2019: -1914.4%FY 2020: 148.0%FY 2021: 184.2%FY 2022: 318.7%FY 2023: -35.1%FY 2024: -8.0%FY 2025: -2.1%
FY 2016 5y median -2.1% FY 2025
ROIC -12.5%
FY 2016: -70.8%FY 2017: -59.8%FY 2018: -76.2%FY 2019: -70.5%FY 2020: -124.8%FY 2021: -74.9%FY 2022: 23.7%FY 2023: -22.3%FY 2024: -13.5%FY 2025: -12.5%
FY 2016 5y median -13.5% FY 2025
ROA -1.5%
FY 2016: -63.1%FY 2017: -53.7%FY 2018: -62.6%FY 2019: -66.2%FY 2020: -101.1%FY 2021: -101.7%FY 2022: 123.8%FY 2023: -23.7%FY 2024: -5.6%FY 2025: -1.5%
FY 2016 5y median -5.6% FY 2025

Growth (YoY)

Revenue 71.6%
FY 2016: -3.9%FY 2017: -13.3%FY 2018: -4.0%FY 2019: 208.4%FY 2020: 30.7%FY 2021: -96.0%FY 2022: 2619.1%FY 2023: -98.1%FY 2024: 35.3%FY 2025: 71.6%
FY 2016 FY 2025
Operating Income 13.0%
FY 2016: -5.9%FY 2017: 14.0%FY 2018: -67.7%FY 2019: -16.1%FY 2020: -2.9%FY 2021: 48.8%FY 2022: 113.4%FY 2023: -179.9%FY 2024: 43.2%FY 2025: 13.0%
FY 2016 FY 2025
EPS (diluted) 74.1%
FY 2016: 6.7%FY 2017: 18.4%FY 2018: -57.5%FY 2019: -35.0%FY 2020: 3.0%FY 2021: 33.0%FY 2022: 148.0%FY 2023: -106.0%FY 2024: 74.3%FY 2025: 74.1%
FY 2016 FY 2025
Free Cash Flow 231.1%
FY 2016: 11.6%FY 2017: -9.4%FY 2018: -66.4%FY 2019: -48.0%FY 2020: 15.0%FY 2021: 8.2%FY 2022: 97.0%FY 2023: 100.0%FY 2024: 0.0%FY 2025: 231.1%
FY 2016 FY 2025

Financial Health

Current Ratio 3.0×
FY 2016: 9.3×FY 2017: 10.5×FY 2018: 4.5×FY 2019: 3.9×FY 2020: 2.2×FY 2021: 0.5×FY 2022: 1.2×FY 2023: 1.7×FY 2024: 1.9×FY 2025: 3.0×
FY 2016 5y median 1.7× FY 2025
Quick Ratio 3.0×
FY 2016: 9.2×FY 2017: 10.4×FY 2018: 4.5×FY 2019: 3.7×FY 2020: 2.0×FY 2021: 0.4×FY 2022: 1.2×FY 2023: 1.7×FY 2024: 1.9×FY 2025: 3.0×
FY 2016 5y median 1.7× FY 2025
Debt / Equity 0.2×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.8×FY 2019: 22.3×FY 2020: -2.0×FY 2021: -2.1×FY 2022: 0.2×FY 2023: 0.3×FY 2024: 0.3×FY 2025: 0.2×
FY 2016 5y median 0.2× FY 2025
Net Debt / EBITDA 0.5×
FY 2016: 1.5×FY 2017: 1.7×FY 2018: 0.7×FY 2019: -0.3×FY 2020: -1.1×FY 2021: -1.7×FY 2022: -2.5×FY 2023: -0.5×FY 2024: -0.5×FY 2025: 0.5×
FY 2016 5y median -0.5× FY 2025
Interest Coverage -527×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: -27.8×FY 2019: -8.7×FY 2020: -5.4×FY 2021: -2.4×FY 2022: 0.0×FY 2023: -42.6×FY 2024: 0.0×FY 2025: -527×
FY 2016 5y median -2.4× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31